ADMA Biologics (NASDAQ:ADMA) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
ADMA Biologics missed estimated earnings by 25.0%, reporting an EPS of $-0.1 versus an estimate of $-0.08.
Revenue was up $13.05 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 8.67% increase in the share price the next day.
Here's a look at ADMA Biologics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.09 | -0.14 | -0.15 | -0.17 |
| EPS Actual | -0.09 | -0.13 | -0.14 | -0.16 |
| Revenue Estimate | 21.76M | 18.72M | 16.42M | 14.58M |
| Revenue Actual | 26.38M | 20.68M | 17.83M | 16.05M |
To track all earnings releases for ADMA Biologics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
